Apollomics Company Profile, Contacts & Intelligence
Apollomics Overview
Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West. Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates across 12 programs that focus on oncology, of which five (5) drug candidates are at clinical stage. The drug candidates in our existing pipeline can be categorized into three (3) groups based on their mechanisms of action, each of which contains drug candidates at different stages of development. The first group is “tumor inhibitors”, which consists of four (4) small molecule inhibitors against different uncontrolled growth signaling pathways in cancer cells, one of which is our Core Product, a c-Met inhibitor. The second group is “anti-cancer enhancers”, which could enhance the anti-cancer effects of other treatments. This group comprises two (2) antagonists against a cell adhesion receptor, which are being developed as adjuncts to chemotherapy. The last group is “immuno-oncology drugs”, which take the advantage of the body’s immune system to fight cancer. This group comprises four (4) drug candidates, including mono-specific and bi-specific antibodies that releases the natural brakes of immune response against cancer cells, as well as a novel cancer vaccine. Having three (3) groups of drug candidates with different mechanisms of action would enable us to develop potential synergistic combination therapies that address unmet needs in cancer treatment. To learn more about Apollomics, visit our website at https://www.apollomicsinc.com/
- Headquarters
- Cn
- Website
- apollomicsinc.com
- Industry
- Biotechnology Research
- Founded
- 2015
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Apollomics Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Apollomics People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Apollomics Workforce Composition
Seniority breakdown across 5 visible profiles.
Compare Similar Companies to Apollomics
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Genentech | Biotechnology Research | 18.23K | View company |
| Arcus Biosciences | Biotechnology | 680 | View company |
| Crown Bioscience | Biotechnology Research | 568 | View company |
| FibroGen, Inc. | Biotechnology Research | 300 | View company |
| ALX Oncology | Biotechnology Research | 73 | View company |
| Imagene Biopharmaceuticals | Biotechnology Research | 41 | View company |
| Launch Therapeutics | Biotechnology | 41 | View company |
| Innoforce Pharmaceuticals | Pharmaceutical Manufacturing | 29 | View company |
| Illexcor Therapeutics, LLC | Biotechnology Research | 6 | View company |
| CBT Pharmaceuticals Inc. | Pharmaceutical Manufacturing | 2 | View company |